Search

Displaying results 8551 - 8560 of 10000 in total
  1. Drug

    Intoplicine

    go.drugbank.com/drugs/DB12868
    Investigational

    Intoplicine has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  2. Drug

    Falnidamol

    go.drugbank.com/drugs/DB12966
    Investigational

    Falnidamol has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.

  3. Drug

    Miridesap

    go.drugbank.com/drugs/DB13087
    Investigational

    Miridesap has been used in trials studying the prevention of HIV and treatment of AL amyloidosis.

  4. Drug

    SB-705498

    go.drugbank.com/drugs/DB11883
    Investigational

    SB-705498 has been investigated for the treatment of Rhinitis, Chronic Cough, and Non-allergic Rhinitis.

  5. Drug

    Fevipiprant

    go.drugbank.com/drugs/DB12011
    Investigational

    Fevipiprant has been used in trials studying the treatment of Asthma, Atopic Dermatitis, and Allergic Rhinitis.

  6. Drug

    Ozoralizumab

    go.drugbank.com/drugs/DB12014
    Investigational

    Ozoralizumab has been used in trials studying the treatment of Rheumatoid Arthritis and Active Rheumatoid Arthritis.

  7. Drug

    Atagabalin

    go.drugbank.com/drugs/DB12032
    Investigational

    Atagabalin has been used in trials studying the treatment of Insomnia, Primary Insomnia, and Nonrestorative Sleep.

  8. Drug

    ORM-12741

    go.drugbank.com/drugs/DB12057
    Investigational

    ORM-12741 has been used in trials studying the basic science and treatment of Alzheimer's Disease.

    Categories: Adrenergic alpha-2 Receptor Antagonists
  9. Drug

    ORG-25935

    go.drugbank.com/drugs/DB12220
    Investigational

    Org 25935 has been used in trials studying the treatment of Alcoholism, Schizophrenia, and Panic Disorder.

  10. Drug

    Brilanestrant

    go.drugbank.com/drugs/DB12253
    Investigational

    ARN-810 has been used in trials studying the basic science and treatment of Breast Cancer.